ORIGINAL RESEARCH
Accepted on 19 Mar 2025
Cost-effectiveness of companion BRCA testing and adjuvant olaparib treatment in patients with BRCA mutated high-risk HER2-negative early breast cancer
doi 10.3389/fonc.2025.1419071
5,868
Total downloads
21k
Total views and downloads
ORIGINAL RESEARCH
Accepted on 19 Mar 2025
ORIGINAL RESEARCH
Accepted on 18 Mar 2025
SYSTEMATIC REVIEW
Published on 04 Mar 2025
CASE REPORT
Published on 11 Feb 2025
ORIGINAL RESEARCH
Published on 06 Feb 2025
ORIGINAL RESEARCH
Published on 20 Jan 2025
REVIEW
Published on 19 Dec 2024
ORIGINAL RESEARCH
Published on 03 Dec 2024
ORIGINAL RESEARCH
Published on 25 Nov 2024
ORIGINAL RESEARCH
Published on 23 Oct 2024
ORIGINAL RESEARCH
Published on 16 Sep 2024
ORIGINAL RESEARCH
Published on 02 Sep 2024